$USNU
Elite Health Systems Inc.

2020 Q1 Form 10-Q Financial Statement

#000114036120011787 Filed on May 15, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q1
Revenue $747.0K $841.0K
YoY Change -11.18%
Cost Of Revenue $79.00K $86.00K
YoY Change -8.14%
Gross Profit $668.0K $755.0K
YoY Change -11.52%
Gross Profit Margin 89.42% 89.77%
Selling, General & Admin $302.0K $308.0K
YoY Change -1.95%
% of Gross Profit 45.21% 40.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change -100.0%
% of Gross Profit 0.0%
Operating Expenses $381.0K $394.0K
YoY Change -3.3%
Operating Profit $366.0K $447.0K
YoY Change -18.12%
Interest Expense $11.00K $29.00K
YoY Change -62.07%
% of Operating Profit 3.01% 6.49%
Other Income/Expense, Net
YoY Change
Pretax Income $233.0K $262.0K
YoY Change -11.07%
Income Tax $58.00K $76.00K
% Of Pretax Income 24.89% 29.01%
Net Earnings $175.0K $186.0K
YoY Change -5.91%
Net Earnings / Revenue 23.43% 22.12%
Basic Earnings Per Share $0.02
Diluted Earnings Per Share $0.02 $23.87K
COMMON SHARES
Basic Shares Outstanding 7.792M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.734M $1.427M
YoY Change 21.51% -37.14%
Cash & Equivalents $1.734M $1.427M
Short-Term Investments
Other Short-Term Assets $96.00K $159.0K
YoY Change -39.62% -36.4%
Inventory
Prepaid Expenses
Receivables $396.0K $2.038M
Other Receivables $1.204M $883.0K
Total Short-Term Assets $3.430M $4.507M
YoY Change -23.9% -1.59%
LONG-TERM ASSETS
Property, Plant & Equipment $120.0K $152.0K
YoY Change -21.05% -95.58%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $222.0K $211.0K
YoY Change 5.21% 31.88%
Other Assets $1.798M
YoY Change
Total Long-Term Assets $1.918M $2.171M
YoY Change -11.65% -40.36%
TOTAL ASSETS
Total Short-Term Assets $3.430M $4.507M
Total Long-Term Assets $1.918M $2.171M
Total Assets $5.348M $6.678M
YoY Change -19.92% -18.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $268.0K $236.0K
YoY Change 13.56% 114.55%
Accrued Expenses $37.00K $33.00K
YoY Change 12.12%
Deferred Revenue $588.0K
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $620.0K $1.449M
YoY Change -57.21% 46.36%
Total Short-Term Liabilities $1.912M $2.389M
YoY Change -19.97% 0.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $620.0K
YoY Change -100.0% -55.4%
Other Long-Term Liabilities $108.0K $145.0K
YoY Change -25.52% -73.15%
Total Long-Term Liabilities $108.0K $765.0K
YoY Change -85.88% -60.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.912M $2.389M
Total Long-Term Liabilities $108.0K $765.0K
Total Liabilities $2.020M $3.481M
YoY Change -41.97% -26.41%
SHAREHOLDERS EQUITY
Retained Earnings $150.0K
YoY Change
Common Stock $3.178M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.328M $3.197M
YoY Change
Total Liabilities & Shareholders Equity $5.348M $6.678M
YoY Change -19.92% -18.76%

Cashflow Statement

Concept 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $175.0K $186.0K
YoY Change -5.91%
Depreciation, Depletion And Amortization $0.00
YoY Change -100.0%
Cash From Operating Activities $752.0K $454.0K
YoY Change 65.64% -31.21%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $17.00K -$228.0K
YoY Change -107.46% -72.2%
Cash From Investing Activities $17.00K -$228.0K
YoY Change -107.46% -72.2%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -370.0K -318.0K
YoY Change 16.35% 22.31%
NET CHANGE
Cash From Operating Activities 752.0K 454.0K
Cash From Investing Activities 17.00K -228.0K
Cash From Financing Activities -370.0K -318.0K
Net Change In Cash 399.0K -92.00K
YoY Change -533.7% -78.1%
FREE CASH FLOW
Cash From Operating Activities $752.0K $454.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q1 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020Q1 dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
CY2020Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2020Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020Q1 dei Entity Registrant Name
EntityRegistrantName
U.S. NeuroSurgical Holdings, Inc.
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
356000
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
396000
CY2020Q1 us-gaap Accounts Receivable Related Parties Noncurrent
AccountsReceivableRelatedPartiesNoncurrent
1401000
CY2020Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001089815
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7792185
CY2020Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2020Q1 dei Document Type
DocumentType
10-Q
CY2020Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q1 dei Entity Shell Company
EntityShellCompany
false
CY2020Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2020Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
268000
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
255000
CY2019Q4 us-gaap Accounts Receivable Related Parties Noncurrent
AccountsReceivableRelatedPartiesNoncurrent
1422000
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
220000
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
399000
CY2020Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3100000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3100000
CY2020Q1 us-gaap Assets
Assets
5348000
CY2019Q4 us-gaap Assets
Assets
4997000
CY2020Q1 us-gaap Assets Current
AssetsCurrent
3430000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
2681000
CY2019Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
176000
CY2020Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
0
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1335000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1519000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1427000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1734000
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1734000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1335000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
399000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-92000
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7792185
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7792185
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7792185
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7792185
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
78000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
78000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
226000
CY2020Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
588000
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
17000
CY2020Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
137000
CY2019Q1 us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
86000
CY2020Q1 us-gaap Health Care Organization Expenses Net
HealthCareOrganizationExpensesNet
79000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
233000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
262000
CY2019Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-194000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-146000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-120000
CY2020Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.04555
CY2020Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
0
CY2020Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
633000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
13000
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.02
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.02
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.25
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.29
CY2020Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
31000
CY2019Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
179000
CY2020Q1 us-gaap Equity Method Investments
EquityMethodInvestments
222000
CY2020Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
13000
CY2020Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
620000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
901000
CY2019Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1449000
CY2019Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
89000
CY2020Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0
CY2019Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
620000
CY2020Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
90000
CY2020Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
543000
CY2020Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
620000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
58000
CY2019Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-34000
CY2020Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-6000
CY2020Q1 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
1204000
CY2019Q4 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
888000
CY2019Q1 us-gaap Net Investment In Lease Current
NetInvestmentInLeaseCurrent
843000
CY2019Q4 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
532000
CY2020Q1 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
0
CY2019Q1 us-gaap Net Investment In Lease Noncurrent
NetInvestmentInLeaseNoncurrent
1204000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
454000
CY2020Q1 us-gaap Interest Expense
InterestExpense
11000
CY2019Q1 us-gaap Interest Expense
InterestExpense
29000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
11000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
752000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-228000
CY2019Q1 us-gaap Interest Paid Net
InterestPaidNet
32000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
45000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
148000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-318000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-370000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
186000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
175000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
33000
CY2020Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
14000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
24000
CY2020Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
46000
CY2020Q1 us-gaap Lease Income
LeaseIncome
2000
CY2019Q1 us-gaap Lease Income
LeaseIncome
0
CY2020Q1 us-gaap Liabilities
Liabilities
2020000
CY2019Q4 us-gaap Liabilities
Liabilities
1844000
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5348000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4997000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1638000
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1912000
CY2019Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
38000
CY2020Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
38000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
128000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
120000
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
152000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
381000
CY2019Q1 us-gaap Operating Expenses
OperatingExpenses
394000
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
362000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
416000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
474000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
24000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-179000
CY2019Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-61000
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05850
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
447000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
366000
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
37000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
36000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
33000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
106000
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
97000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
134000
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
134000
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
96000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
102000
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1798000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2188000
CY2020Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
-9000
CY2019Q1 us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
0
CY2020Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
172000
CY2019Q1 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
430000
CY2019Q1 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
0
CY2020Q1 us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
36000
CY2019Q1 us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
202000
CY2020Q1 us-gaap Proceeds From Collection Of Lease Receivables
ProceedsFromCollectionOfLeaseReceivables
216000
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
120000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
128000
CY2019Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
161000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2019Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
318000
CY2020Q1 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
370000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-25000
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
150000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
747000
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
841000
CY2019Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
38000
CY2020Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
24000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
302000
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
308000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
3153000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
3328000
CY2019Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7792185
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7792185
CY2019Q1 usnu Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
9000
CY2020Q1 usnu Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
8000
CY2020Q1 usnu Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
8000
CY2019Q1 usnu Increase Decrease In Operating Lease Right Of Use Liability
IncreaseDecreaseInOperatingLeaseRightOfUseLiability
9000
CY2019Q1 usnu Operating Leases Deferred Rent Derecognition
OperatingLeasesDeferredRentDerecognition
15000
CY2020Q1 usnu Operating Leases Deferred Rent Derecognition
OperatingLeasesDeferredRentDerecognition
0
CY2020Q1 usnu Amount Of Guarantee Obligations Noncurrent
AmountOfGuaranteeObligationsNoncurrent
11000
CY2019Q4 usnu Amount Of Guarantee Obligations Noncurrent
AmountOfGuaranteeObligationsNoncurrent
11000
CY2020Q1 usnu Renovation Installation And Operation Agreement Period
RenovationInstallationAndOperationAgreementPeriod
P14Y
CY2019Q1 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
2199000
CY2020Q1 usnu Total Leased Assets Operating And Financing
TotalLeasedAssetsOperatingAndFinancing
1324000
CY2019Q1 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
2236000
CY2020Q1 usnu Total Lease Liabilities Operating And Finance
TotalLeaseLiabilitiesOperatingAndFinance
754000

Files In Submission

Name View Source Status
0001140361-20-011787-index-headers.html Edgar Link pending
0001140361-20-011787-index.html Edgar Link pending
0001140361-20-011787.txt Edgar Link pending
0001140361-20-011787-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex32_1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usnu-20200331.xml Edgar Link completed
usnu-20200331.xsd Edgar Link pending
usnu-20200331_cal.xml Edgar Link unprocessable
usnu-20200331_def.xml Edgar Link unprocessable
usnu-20200331_lab.xml Edgar Link unprocessable
usnu-20200331_pre.xml Edgar Link unprocessable